According to Standard BioTools's latest financial reports and stock price the company's current Operating Margin is -132.79%. At the end of 2022 the company had an Operating Margin of -196.97%.
Year | Operating Margin | Change |
---|---|---|
2022 | -196.97% | 304.03% |
2021 | -48.75% | 24.48% |
2020 | -39.16% | -31.17% |
2019 | -56.89% | 4.64% |
2018 | -54.37% | -13.13% |
2017 | -62.59% | -18.47% |
2016 | -76.76% | 60.72% |
2015 | -47.76% | -3.61% |
2014 | -49.55% | 124.88% |
2013 | -22.03% | -38.95% |
2012 | -36.09% | -30.64% |
2011 | -52.03% | 3.82% |
2010 | -50.12% | -33.59% |
2009 | -75.47% | -60.93% |
2008 | -193.17% | -44.55% |
2007 | -348.40% | -5.36% |
2006 | -368.13% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.